Senior Paralegal, RayzeBio at Bristol-Myers Squibb

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Onsite presence in San Diego, California is required
Non-attorney position
Ability to collaborate closely with attorneys to understand and support clients’ contracting needs and priorities
Serve as the first legal escalation point, reviewing and responding to third-party redlines
Support business stakeholders in understanding potential risks
Conduct redline reviews, answer questions, and provide appropriate guidance and training to contract facilitators and other internal stakeholders

Responsibilities

Draft, review, redline, and negotiate procurement and commercial contracts, including confidentiality agreements, material transfer agreements, services agreements, and other procurement agreements
Partner closely with RayzeBio Procurement to align contract terms to business and operational objectives while ensuring compliance with applicable laws and corporate policies
Provide guidance and explanation of risks on contract matters to internal stakeholders including procurement and business units
Support contract lifecycle management processes ensuring proper use of the iCertis CLM system for contract intakes, approvals, tracking, and reporting
Develop and maintain fallback guidance, playbooks, and other internal contract legal support guidance documents
For legal-led transactions (description incomplete in provided text)

Skills

Legal Research

Contract Drafting

Regulatory Compliance

Intellectual Property

Corporate Governance

Litigation Support

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free